Answers are grounded in this paper and cite their sources.
Novel technologies were developed and used for the synthesis and evaluation of new triazolopyridazine BRD9 inhibitors.
No takes yet. Share an insight, caveat, or question.
Guetzoyan et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: